Peter S. Whitton

4.6k citations
78 papers · 3.9k indexed · 2 hit papers · h-index 31

Impact in

Papers in

Peter S. Whitton

78 papers receiving 3.8k citations

Hit Papers

Exenatide and the treatment of patients with Parkinson’s disease 2013 · 414 citations
4142007202620132019100200300400500

Peers

Peter S. Whitton
Comparison fields: 5 of 107
  • Cellular and Molecular Neuroscience 2.2k
  • Biological Psychiatry 210
  • Behavioral Neuroscience 259
  • Neurology 921
  • Neurology 425
Replace Michael F. Mazurek with:
Michael F. Mazurek Canada
I J Kopin United States
Warren D. Hirst United States
Hans Nissbrandt Sweden
Marc Morissette Canada
N.M.J. Rupniak United Kingdom
Hiroshi Ujike Japan
Konrad Talbot United States
J.C. Stoof Netherlands
Alena Savonenko United States
Peter S. Whitton relative to Michael F. Mazurek Canada Michael F. Mazurek's profile →
Citations per field
00.5×1.5×2.4×
Michael F. Mazurek · 1×
Citations per year

Countries citing papers authored by Peter S. Whitton

Since Specialization
Citations

This map shows the geographic impact of Peter S. Whitton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Whitton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Whitton more than expected).

Fields of papers citing papers by Peter S. Whitton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Whitton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Whitton. The network helps show where Peter S. Whitton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter S. Whitton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter S. Whitton Line = papers co-authored together Peter S. Whitton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2014242
2 201035
3 200810
4 200811
5
Urocortin restores striatal extracellular DA in the 6-hydroxydopamine hemiparkinsonian rat
20071
6 200718
7 200615
8 200610
9
Evidence for a neuroprotective role of the CRH-like peptide, urocortin, in the 6-hydroxydopamine treated rat
20051
10 20044
11 200437
12 20048
13 19997
14 199610
15 199593
16 199257
17 199154
18 199143
19 198819
20 198814

About Peter S. Whitton

Peter S. Whitton is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience, Biological Psychiatry, Psychiatry and Mental health and Physiology, having authored 78 papers that have together received 3.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (43 papers), Neurotransmitter Receptor Influence on Behavior (21 papers), Epilepsy research and treatment (12 papers), Pharmacological Effects and Toxicity Studies (10 papers), Nitric Oxide and Endothelin Effects (9 papers), Biochemical effects in animals (9 papers), Stress Responses and Cortisol (8 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.2k citations), Biological Psychiatry (210 citations), Behavioral Neuroscience (259 citations), Neurology (921 citations) and Neurology (425 citations). Peter S. Whitton has collaborated with scholars based in United Kingdom, Mexico and Italy. Frequent co-authors include G. Curzon, Leslie J. Fowler, Christopher S. Biggs, Alexander Harkavyi, L.J. Fowler, C.S. Biggs, G.A. Kennett, Joanna Segieth, Andrew J. Lees and Amjad Abuirmeileh. Their work appears in journals such as Brain Research, Journal of Neurochemistry, European Journal of Pharmacology, British Journal of Pharmacology and Journal of Pharmacy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026